Patents by Inventor Justin Hughey
Justin Hughey has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20220394960Abstract: Fisherman bowfish by using a bow with an arrow having a fishing head on an arrow. The arrow is shot at the fish using the bow, with a fishing line attached to the arrow. A tip portion of a body of the fishing head impacts the fish and movement, resulting in movement between the body and a plunger along an impact axis. This movement causes the plunger to contact blades retracted within the body, such that the blades pivot from a retracted position to an extended position. In the extended position, the blades engage the fish, such that the blades engage the fish if the fishing head is pulled backward in the direction of entry into the fish. For removal, the fishing head is pushed along the same direction of entry, which causes the blades to automatically retract.Type: ApplicationFiled: June 14, 2022Publication date: December 15, 2022Inventor: Justin Hughey
-
Publication number: 20200368169Abstract: Described herein are abuse deterrent controlled release oral pharmaceutical compositions comprising and methods for making the same. In particular, an abuse deterrent controlled release oral pharmaceutical composition comprising a soft capsule and an abuse deterrent controlled release matrix comprising an active pharmaceutical ingredient are described.Type: ApplicationFiled: August 11, 2020Publication date: November 26, 2020Inventors: Saujanya Gosangari, Justin Hughey, Tatyana Dyakonov, George VAMVAKAS, Aqeel A. FATMI
-
Patent number: 10772842Abstract: Described herein are abuse deterrent controlled release oral pharmaceutical compositions comprising and methods for making the same. In particular, an abuse deterrent controlled release oral pharmaceutical composition comprising a soft capsule and an abuse deterrent controlled release matrix comprising an active pharmaceutical ingredient are described.Type: GrantFiled: October 7, 2015Date of Patent: September 15, 2020Assignee: PATHEON SOFTGELS INC.Inventors: Saujanya Gosangari, Justin Hughey, Tatyana Dyakonov, George Vamvakas, Aqeel A. Fatmi
-
Patent number: 10478429Abstract: Described herein are oral abuse deterrent pharmaceutical compositions, methods for making the same, and methods for treating pain by administering the pharmaceutical composition to a subject in need thereof. In particular, an oral abuse deterrent pharmaceutical composition comprising a soft capsule and a controlled release matrix comprising oxycodone are described.Type: GrantFiled: October 27, 2017Date of Patent: November 19, 2019Assignee: Patheon Softgels, Inc.Inventors: Justin Hughey, Saujanya Gosangari, Chue Hue Yang
-
Patent number: 10335375Abstract: Described herein are abuse deterrent oral pharmaceutical compositions, methods for making the same, and methods of treatment using such compositions. In particular, oral pharmaceutical compositions that mitigate the risk of overingestion of one or more active pharmaceutical ingredients are described.Type: GrantFiled: May 29, 2018Date of Patent: July 2, 2019Assignee: Patheon Softgels, Inc.Inventors: Justin Hughey, Jason Vaughn
-
Patent number: 10195211Abstract: Described herein are topical, non-systemic, slow releasing oral pharmaceutical compositions, methods for making the same, and methods for treating subjects in need thereof with such compositions. In particular, the oral composition provides topical, non-systemic administration of one or more active pharmaceutical ingredients to the oral cavity and upper gastrointestinal track, including the esophagus. In one embodiment, the pharmaceutical composition provides topical corticosteroids to the esophagus and oral cavity.Type: GrantFiled: October 27, 2017Date of Patent: February 5, 2019Assignee: Patheon Softgels, Inc.Inventors: YinYan Zhao, Justin Hughey, Jason Vaughn, Qi Fang
-
Patent number: 10188662Abstract: Described herein are oral pharmaceutical compositions suitable for chewing, sucking, or buccal dissolution comprising non-systemic corticosteroid soft lozenges, methods for making the same, and methods for treating subjects in need thereof with such lozenges. In particular, the oral composition provides topical, non-systemic administration of one or more active pharmaceutical ingredients to the oral cavity and upper gastrointestinal track, including the esophagus. In one embodiment, the oral pharmaceutical compositions comprise chewable, suckable, or buccally-dissolvable soft lozenges for the treatment of esophageal lesions. The soft lozenges provide topical, non-systemic delivery of corticosteroids to the esophagus and oral cavity.Type: GrantFiled: October 27, 2017Date of Patent: January 29, 2019Assignee: Patheon Softgels, Inc.Inventors: YinYan Zhao, Justin Hughey, Jason Vaughn, Qi Fang
-
Publication number: 20180344651Abstract: Described herein are abuse deterrent oral pharmaceutical compositions, methods for making the same, and methods of treatment using such compositions. In particular, oral pharmaceutical compositions that mitigate the risk of overingestion of one or more active pharmaceutical ingredients are described.Type: ApplicationFiled: May 29, 2018Publication date: December 6, 2018Inventors: Justin HUGHEY, Jason VAUGHN
-
Patent number: 9943513Abstract: Described herein are oral abuse deterrent pharmaceutical compositions, methods for making the same, and methods for treating pain by administering the pharmaceutical composition to a subject in need thereof. In particular, an oral abuse deterrent pharmaceutical composition comprising a soft capsule and a controlled release matrix comprising oxycodone are described.Type: GrantFiled: October 5, 2016Date of Patent: April 17, 2018Assignee: BANNER LIFE SCIENCES LLCInventors: Justin Hughey, Saujanya Gosangari, Chue Hue Yang
-
Publication number: 20180078502Abstract: Described herein are topical, non-systemic, slow releasing oral pharmaceutical compositions, methods for making the same, and methods for treating subjects in need thereof with such compositions. In particular, the oral composition provides topical, non-systemic administration of one or more active pharmaceutical ingredients to the oral cavity and upper gastrointestinal track, including the esophagus. In one embodiment, the pharmaceutical composition provides topical corticosteroids to the esophagus and oral cavity.Type: ApplicationFiled: October 27, 2017Publication date: March 22, 2018Inventors: YinYan Zhao, Justin Hughey, Jason Vaughn, Qi Fang
-
Publication number: 20180055837Abstract: Described herein are oral abuse deterrent pharmaceutical compositions, methods for making the same, and methods for treating pain by administering the pharmaceutical composition to a subject in need thereof. In particular, an oral abuse deterrent pharmaceutical composition comprising a soft capsule and a controlled release matrix comprising oxycodone are described.Type: ApplicationFiled: October 27, 2017Publication date: March 1, 2018Inventors: Justin Hughey, Saujanya Gosangari, Chue Hue Yang
-
Publication number: 20180042940Abstract: Described herein are oral pharmaceutical compositions suitable for chewing, sucking, or buccal dissolution comprising non-systemic corticosteroid soft lozenges, methods for making the same, and methods for treating subjects in need thereof with such lozenges. In particular, the oral composition provides topical, non-systemic administration of one or more active pharmaceutical ingredients to the oral cavity and upper gastrointestinal track, including the esophagus. In one embodiment, the oral pharmaceutical compositions comprise chewable, suckable, or buccally-dissolvable soft lozenges for the treatment of esophageal lesions. The soft lozenges provide topical, non-systemic delivery of corticosteroids to the esophagus and oral cavity.Type: ApplicationFiled: October 27, 2017Publication date: February 15, 2018Inventors: YinYan Zhao, Justin Hughey, Jason Vaughn, Qi Fang
-
Patent number: 9877971Abstract: Described herein are oral pharmaceutical compositions suitable for chewing, sucking, or buccal dissolution comprising non-systemic corticosteroid soft lozenges, methods for making the same, and methods for treating subjects in need thereof with such lozenges. In particular, the oral composition provides topical, non-systemic administration of one or more active pharmaceutical ingredients to the oral cavity and upper gastrointestinal track, including the esophagus. In one embodiment, the oral pharmaceutical compositions comprise chewable, suckable, or buccally-dissolvable soft lozenges for the treatment of esophageal lesions. The soft lozenges provide topical, non-systemic delivery of corticosteroids to the esophagus and oral cavity.Type: GrantFiled: June 14, 2016Date of Patent: January 30, 2018Assignee: Banner Life Sciences LLCInventors: Yinyan Zhao, Justin Hughey, Jason Vaughn, Qi Fang
-
Patent number: 9867834Abstract: Described herein are topical, non-systemic, slow releasing oral pharmaceutical compositions, methods for making the same, and methods for treating subjects in need thereof with such compositions. In particular, the oral composition provides topical, non-systemic administration of one or more active pharmaceutical ingredients to the oral cavity and upper gastrointestinal track, including the esophagus. In one embodiment, the pharmaceutical composition provides topical corticosteroids to the esophagus and oral cavity.Type: GrantFiled: October 14, 2016Date of Patent: January 16, 2018Assignee: Banner Life Sciences LLCInventors: Yinyan Zhao, Justin Hughey, Jason Vaughn, Qi Fang
-
Patent number: 9861629Abstract: Described herein are oral abuse deterrent pharmaceutical compositions, methods for making the same, and methods for treating pain by administering the pharmaceutical composition to a subject in need thereof. In particular, an oral abuse deterrent pharmaceutical composition comprising a soft capsule and a controlled release matrix comprising oxycodone are described.Type: GrantFiled: October 5, 2016Date of Patent: January 9, 2018Assignee: Banner Life Sciences LLCInventors: Justin Hughey, Saujanya Gosangari, Chue Hue Yang
-
Publication number: 20170065613Abstract: Described herein are topical, non-systemic, slow releasing oral pharmaceutical compositions, methods for making the same, and methods for treating subjects in need thereof with such compositions. In particular, the oral composition provides topical, non-systemic administration of one or more active pharmaceutical ingredients to the oral cavity and upper gastrointestinal track, including the esophagus. In one embodiment, the pharmaceutical composition provides topical corticosteroids to the esophagus and oral cavity.Type: ApplicationFiled: October 14, 2016Publication date: March 9, 2017Inventors: Yinyan Zhao, Justin Hughey, Jason Vaughn, Qi Fang
-
Publication number: 20160361320Abstract: Described herein are oral pharmaceutical compositions suitable for chewing, sucking, or buccal dissolution comprising non-systemic corticosteroid soft lozenges, methods for making the same, and methods for treating subjects in need thereof with such lozenges. In particular, the oral composition provides topical, non-systemic administration of one or more active pharmaceutical ingredients to the oral cavity and upper gastrointestinal track, including the esophagus. In one embodiment, the oral pharmaceutical compositions comprise chewable, suckable, or buccally-dissolvable soft lozenges for the treatment of esophageal lesions. The soft lozenges provide topical, non-systemic delivery of corticosteroids to the esophagus and oral cavity.Type: ApplicationFiled: June 14, 2016Publication date: December 15, 2016Inventors: Yinyan Zhao, Justin Hughey, Jason Vaughn, Qi Fang
-
Publication number: 20160199368Abstract: Described herein are abuse deterrent controlled release oral pharmaceutical compositions comprising and methods for making the same. In particular, an abuse deterrent controlled release oral pharmaceutical composition comprising a soft capsule and an abuse deterrent controlled release matrix comprising an active pharmaceutical ingredient are described.Type: ApplicationFiled: October 7, 2015Publication date: July 14, 2016Inventors: Saujanya Gosangari, Justin Hughey, Tatyana Dyakonov, George VAMVAKAS, Aqeel A. FATMI
-
Publication number: 20140039031Abstract: The present disclosure is directed to compositions and methods for formulating a pharmaceutical dosage form by forming a composition comprising acetyl-11-keto-?-boswellic acid, diindolylmethane, or curcumin with one or more pharmaceutically acceptable excipients for enhanced solubility to increase bioavailability and improve therapeutic efficacy. The composition can be processed by thermo-kinetic compounding along with conventional methods known in the art, such as hot melt extrusion, melt granulation, compression molding, tablet compression, capsule filling, film-coating, or injection molding.Type: ApplicationFiled: February 23, 2012Publication date: February 6, 2014Applicants: Dispersol Technologies. LLC, Board of Regents, The University of Texas SystemInventors: Chris Brough, Robert O. Williams, III, James W. McGinity, Dave A. Miller, Justin Hughey, Ryan Bennett
-
Publication number: 20100047345Abstract: Disclosed herein are oral dosage forms of hydromorphone that are resistant to abuse and methods of their formulation. In particular, oral dosage forms that are resistant to dissolution in aqueous solutions of ethanol are described.Type: ApplicationFiled: November 4, 2009Publication date: February 25, 2010Inventors: Michael M. Crowley, Feng Zhang, John Koleng, Justin Keen, Jason Vaughn, Justin Hughey